Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
World Journal of Urology|August 15, 2018
Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancerMario I Fernández, Maurizio Brausi, Peter E Clark, et al.
The Journal of Urology|September 25, 2012
Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experienceSamuel D Kaffenberger, Kirk A Keegan, Neil K Bansal, et al.
American Journal of Human Genetics|March 4, 2014
An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibilityJoan P Breyer, Daniel C Dorset, Travis A Clark, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IIWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Urology|January 16, 2007
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomesMichael S Cookson, Gunnar Aus, Arthur L Burnett, et al.
Plos One|May 17, 2012
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferationDavid J DeGraff, Peter E Clark, Justin M Cates, et al.
The Journal of Urology|June 16, 2007
Erectile function outcome reporting after clinically localized prostate cancer treatmentArthur L Burnett, Gunnar Aus, Edith D Canby-Hagino, et al.
Nature Reviews. Urology|September 24, 2014
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USASiamak Daneshmand, Anne K Schuckman, Bernard H Bochner, et al.
European Urology|May 22, 2025
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerMarie-Pier St-Laurent, Parminder Singh, David J McConkey, et al.
Pageof 22